MarkPatrickConnorMD

PubMed

• Employing the Operational Model to Measure System-Independent OTR Efficacy
  Kiyan Afzali, Mark Connor> ;Methods in Molecular Biology. 2022 Jan 1
• Lifetime-Engineered Ruby Nanoparticles (Tau-Rubies) for Multiplexed Imaging of μ-Opioid Receptors.
  Xiaohong Yang, Alireza Maleki, Nikolay A. Lipey, Xianlin Zheng, Marina Santiago, Mark Connor, Varun K. A. Sreenivasan, Judith M. Dawes, Yiqing Lu, Andrei V. Zvyagin> ;ACS Sensors. 2021 Mar 4
• 13 citations
  Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro.
  Chris Bladen, Somayeh Mirlohi, Marina Santiago, Mitchell Longworth, Michael Kassiou, Samuel D. Banister, Mark Connor> ;Neuropharmacology. 2021 Apr 1
• 6 citations
  Modulation of Recombinant Human T-Type Calcium Channels by Δ9-Tetrahydrocannabinolic Acid In Vitro
  Somayeh Mirlohi, Chris Bladen, Marina Santiago, Mark Connor> ;Cannabis and Cannabinoid Research. 2021 Jan 21
• 3 citations
  The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonist.
  Michael Moir, Samuel Lane, Andrew P. Montgomery, David E. Hibbs, Mark Connor, Michael Kassiou> ;European Journal of Medicinal Chemistry. 2021 Jan 15
• 3 citations
  Do gabapentin or pregabalin directly modulate the µ receptor
  Preeti Manandhar, Bridin Murnion, Natasha L. Grimsey, Mark Connor, Marina Santiago> ;Peerj. 2021 Apr 12
• Functionalization and Bioconjugation of Nanoruby for Long-Term, Ultrasensitive Imaging of Μu-Opioid Receptors.
  Rashmi R. Pillai, Mark Connor, Varun K. A. Sreenivasan> ;Methods in Molecular Biology. 2021 Jan 1
• 11 citations
  Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-P...
  Adam Ametovski, Christa MacDonald, Jamie J. Manning, S. A. Syed Haneef, Marina Santiago, Lewis J. Martin, Eric Sparkes, Andrew Reckers, Roy Gerona, Mark Connor, Michel...> ;ACS Chemical Neuroscience. 2020 Nov 4
• 16 citations
  Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists.
  Shivani Sachdev, Samuel D. Banister, Marina Santiago, Chris Bladen, Michael Kassiou, Mark Connor> ;Pharmacology Research & Perspectives. 2020 Apr 1
• 207 citations
  Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.
  Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer, Julie Sanchez, Herman D. Lim, Claudia Alamein, Preeti Manandhar, Marina Santiago, Sebastian Fritzwanker, Frank Sch...> ;Science Signaling. 2020 Mar 31
• 29 citations
  Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels.
  Marika Heblinski, Marina Santiago, Charlotte Fletcher, Jordyn Stuart, Mark Connor, Iain S. McGregor, Jonathon C. Arnold> ;Cannabis and Cannabinoid Research. 2020 Dec 15
• 37 citations
  In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors.
  Shivani Sachdev, Kiran Vemuri, Samuel D. Banister, Mitchell Longworth, Michael Kassiou, Marina Santiago, Alexandros Makriyannis, Mark Connor> ;British Journal of Pharmacology. 2019 Dec 1
• 54 citations
  Cannabichromene is a cannabinoid CB2 receptor agonist.
  Michael Philip Udoh, Marina Santiago, Steven O. Devenish, Iain S. McGregor, Mark Connor> ;British Journal of Pharmacology. 2019 Dec 1
• 12 citations
  Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids
  Michael Moir, Samuel Lane, Felcia Lai, Mark Connor, David E. Hibbs, Michael Kassiou> ;European Journal of Medicinal Chemistry. 2019 Oct 15
• 7 citations
  Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells
  Shivani Sachdev, Rochelle Boyd, Natasha L. Grimsey, Marina Santiago, Mark Connor> ;Peerj. 2019 Sep 25
• 68 citations
  Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors.
  Marina Santiago, Shivani Sachdev, Jonathon C. Arnold, Iain S. McGregor, Mark Connor> ;Cannabis and Cannabinoid Research. 2019 Sep 23
• 13 citations
  The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F‐PY‐PICA, 5F‐PY‐PINACA, and their analogs
  Samuel D. Banister, Richard C. Kevin, Lewis J. Martin, Axel Adams, Christa MacDonald, Jamie J. Manning, Rochelle Boyd, Michael. J. Cunningham, Marc Y. Stevens, Iain S....> ;Drug Testing and Analysis. 2019 Jul 1
• 28 citations
  CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
  Richard C. Kevin, Lyndsey L. Anderson, Iain S. McGregor, Rochelle Boyd, Jamie J. Manning, Michelle Glass, Mark Connor, Samuel D. Banister> ;Frontiers in Pharmacology. 2019 May 29
• 7 citations
  Synthesis and: In vitro evaluation of fluorine-18 benzimidazole sulfones as CB2 PET-radioligands
  Annukka Kallinen, Rochelle Boyd, Samuel Lane, Rajiv Bhalla, Karine Mardon, Damion H.R. Stimson, Eryn L. Werry, Roger Fulton, Mark Connor, Michael Kassiou> ;Organic & Biomolecular Chemistry. 2019 May 22
• 33 citations
  Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CU...
  Samuel D. Banister, Axel Adams, Richard C. Kevin, Christa MacDonald, Michelle Glass, Rochelle Boyd, Mark Connor, Iain S. McGregor, Christopher Havel, Stephen Bright, M...> ;Drug Testing and Analysis. 2019 Feb 1
• 3 citations
  Regulation of heterologously expressed 5-HT1B receptors coupling to potassium channels in AtT-20 cells
  Marika Heblinski, Chris Bladen, Mark Connor> ;British Journal of Pharmacology. 2019 Feb 1
• 43 citations
  Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol.
  Samuel D. Banister, Jonathon C. Arnold, Mark Connor, Michelle Glass, Iain S. McGregor> ;ACS Chemical Neuroscience. 2019 Jan 28
• 12 citations
  The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution.
  Samuel D Banister, Mark Connor> ;Handbook of Experimental Pharmacology. 2018 Aug 15
• 17 citations
  The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.
  Samuel D Banister, Mark Connor> ;Handbook of Experimental Pharmacology. 2018 Jul 8
• 10 citations
  The chemistry and pharmacology of synthetic cannabinoid SDB-006 and its regioisomeric fluorinated and methoxylated analogs
  Samuel D. Banister, Alexander Olson, Matthew Winchester, Jordyn Stuart, Amelia R. Edington, Richard C. Kevin, Mitchell Longworth, Marco Herrera, Mark Connor, Iain S. M...> ;Drug Testing and Analysis. 2018 Jul 1
• Join now to see all